Anticoagulant activities of heparin and fragments.
Barrowcliffe
T W
TW
National Institute for Biological Standards and Control Potters Bar, Hertfordshire, United Kingdom.
Thomas
D P
DP
D001777:Blood Coagulation / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D005165:Factor V / Q000378:metabolism; D005172:Factor XI / Q000037:antagonists & inhibitors; D005174:Factor XII / Q000037:antagonists & inhibitors; D015956:Factor XIIa; D015945:Factor XIa; D015951:Factor Xa; D006493:Heparin / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism; D015842:Serine Proteinase Inhibitors; D013917:Thrombin / Q000037:antagonists & inhibitors
D010743:Phospholipids; D015842:Serine Proteinase Inhibitors; D005165:Factor V; D005174:Factor XII; D006493:Heparin; D005172:Factor XI; D015945:Factor XIa; D015956:Factor XIIa; D013917:Thrombin; D015951:Factor Xa; D002118:Calcium